Today: 8 June 2026
Standard Chartered shares slide after CFO quits for Apollo as results near
10 February 2026
2 mins read

Standard Chartered shares slide after CFO quits for Apollo as results near

London, Feb 10, 2026, 12:05 GMT — Regular session

  • Shares of Standard Chartered dropped roughly 4% as CFO Diego De Giorgi departed the bank with immediate effect.
  • Peter Burrill, the deputy CFO, steps in as interim finance chief.
  • Investors are waiting for the bank’s full-year results on Feb. 24, hoping those numbers shed some light on both its strategy and who’s next in line for leadership.

Shares of Standard Chartered slipped Tuesday after news broke that CFO Diego De Giorgi was out. The stock, listed in London, dropped 4.4% to 1,816 pence, down from Monday’s close at 1,899.

Standard Chartered’s finance chief is out just weeks ahead of the company’s full-year results—an announcement where the CFO usually lays out guidance and capital strategy. The timing slices through an ongoing revamp meant to sharpen returns and boost efficiency, according to the bank.

Jefferies analysts described the exit as “a particular blow,” highlighting De Giorgi’s hand in the “Fit for Growth” cost and efficiency overhaul. They also noted his contributions to investor communications—moves they said supported the bank’s valuation. https://www.marketscreener.com/news/standa…

Standard Chartered has tapped deputy CFO Peter Burrill to step in as interim group CFO, with the bank saying a search for a permanent successor is underway. CEO Bill Winters called Burrill “provides valuable continuity” for the finance team. https://www.sc.com/en/press-release/appoin…

The bank stated that De Giorgi’s resignation didn’t trigger any issues requiring disclosure to shareholders. It also clarified he’s out of the running for a 2025 annual incentive and won’t be getting a 2026 LTIP award—a long-term share-based payout.

Apollo has tapped De Giorgi as its new partner and EMEA chief, the firm announced. President Jim Zelter called the region a “growth engine” for Apollo. De Giorgi, for his part, said he’s “long viewed Apollo as one of the most innovative firms in financial services.” https://www.apollo.com/insights-news/press…

Standard Chartered’s Hong Kong shares tumbled as much as 6.4% at one point, then pared back some of those losses, according to Reuters. The bank, pushing a strategy that leans more toward Asia and Africa, has tried to set itself apart from UK rivals like HSBC.

Monday’s announcement of a new CFO followed another shuffle: Standard Chartered tapped ex-UBS banker Raza Jafree to take over as global head of private client sales, part of the bank’s push to tighten the relationship between its investment bank and wealth arm.

Investors are watching closely to see if the finance team can maintain discipline on costs, capital, and buybacks without missing a beat. Leadership changes have drawn attention across major UK banks; in the market, De Giorgi was viewed as a possible contender for the CEO role.

Even so, any quick move in the shares might not stick if Standard Chartered’s upcoming update backs up its earnings and return goals. Over the past year, results and guidance have pushed the stock, with investors responding to more transparency around costs and capital.

Right now, traders are alert to possible shifts on the board or among senior management. They’re also scrutinizing how Standard Chartered approaches investor communications before results come out.

Looking ahead, Feb. 24 marks the next major event: Standard Chartered will release its Q4 and full-year 2025 results.

Stock Market Today

  • Yelp Shares Fall 14% in a Month Amid AI Growth and Market Pressure
    June 8, 2026, 10:03 AM EDT. Yelp (YELP) shares dropped 14% over the past month and 23% year to date, reflecting weaker long-term shareholder returns. Despite recent price weakness, Simply Wall St values Yelp at $30.82, suggesting it is 24.6% undervalued compared to the current $23.25 share price. The stock's valuation is supported by a 10x surge in AI search API usage and a $10 million AI data licensing run-rate, signaling potential high-margin B2B revenue growth. However, softer advertising demand and intensified competition in search challenge Yelp's growth outlook. Investors are advised to weigh these mixed signals and assess key growth assumptions alongside risks before making decisions.

Latest articles

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

8 June 2026
Amazon’s new multibillion-dollar supply deal makes Corning a key fiber provider for U.S. data centers, but with shares up 305% in 12 months and investors already pricing in big AI wins, the stock was little changed at $177.58 premarket as risks of factory delays and high expectations loom.
BlackBerry Shares Stall After QNX Push

BlackBerry Stock Moves in Pre-Market Ahead of June Test

8 June 2026
BlackBerry’s U.S. shares rose 2.34% in premarket trading to $9.63 after Friday’s 8.99% drop, but with analyst targets averaging just $4.98, investors are betting on QNX growth and secure-communications wins ahead of June 25 earnings; any disappointment could hit the stock hard.
Micron Technology Stock Surges as AI Memory Shortage Puts MU at Center of Chip Rally

Micron Shares Edge Up in Premarket; Investors Await Next AI Test

8 June 2026
Micron surged 8.2% to $935.07 in Nasdaq premarket after Friday’s $127 billion rout, as investors cheered Nvidia’s confirmation it will keep sourcing high-bandwidth memory from Micron and Samsung, easing fears SK Hynix would become exclusive supplier; Cantor Fitzgerald raised its price target to $1,500, with Micron’s next earnings report due June 24.
Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

8 June 2026
Tango shares soared up to 48% in premarket trading after reporting a 92% objective response rate and 90% six-month progression-free survival in a 12-patient pancreatic cancer trial, with plans to advance the vopimetostat-daraxonrasib combo to Phase 3 testing in first-line MTAP-deleted pancreatic cancer.
BAT share price slips again as buyback filing lands and Capital Group trims stake ahead of results
Previous Story

BAT share price slips again as buyback filing lands and Capital Group trims stake ahead of results

Legal & General share price slips as AI disruption worries keep UK insurers on edge
Next Story

Legal & General share price slips as AI disruption worries keep UK insurers on edge

Go toTop